🏅 Antleron is one of the awarded companies within the INNOVATION FINANCIAL SUPPORT category.

Antleron is a Leuven-based R&D scale-up that develops custom cell-based bioprocess solutions across a wide range of life science applications, with a focus on advanced and personalized therapies, diagnostics and organs-on-chips. Using unique technology toolbox that combines digital twins and 3D printing with the power of cells, the Antleron team of multidisciplinary specialists invents and develops novel biomanufacturing solutions and infrastructure platforms. These solutions will enable next-generation cell and gene therapies to reach patient faster and treat all those in need in a socio-economically more sustainable way.

“The BioMan4R2 program enabled us to perform additional validation work for our CellGuide® platform and to extend its use to a new application and customer segment. The BioMan4R2 call provided comprehensible access to EU funding, meeting relevant needs of small companies, such as Antleron. The coordinators from the main office have been helpful throughout the process. The administration required was appropriate for this size of project, letting us focus on the main activity, i.e., delivering innovative solutions for customers active in bioprocesses and biomanufacturing.”

Follow all BioMan4R2 success stories and achievements on LinkedIn!